Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke.

Pravalika K, Sarmah D, Kaur H, Vats K, Saraf J, Wanve M, Kalia K, Borah A, Yavagal DR, Dave KR, Bhattacharya P.

Life Sci. 2018 Nov 7. pii: S0024-3205(18)30720-3. doi: 10.1016/j.lfs.2018.11.014. [Epub ahead of print]

PMID:
30414429
2.

Resveratrol Preconditioning Induces Genomic and Metabolic Adaptations within the Long-Term Window of Cerebral Ischemic Tolerance Leading to Bioenergetic Efficiency.

Khoury N, Xu J, Stegelmann SD, Jackson CW, Koronowski KB, Dave KR, Young JI, Perez-Pinzon MA.

Mol Neurobiol. 2018 Oct 20. doi: 10.1007/s12035-018-1380-6. [Epub ahead of print]

PMID:
30343466
3.

Therapeutic spectrum of interferon-β in ischemic stroke.

Wanve M, Kaur H, Sarmah D, Saraf J, Pravalika K, Vats K, Kalia K, Borah A, Yavagal DR, Dave KR, Bhattacharya P.

J Neurosci Res. 2018 Oct 15. doi: 10.1002/jnr.24333. [Epub ahead of print] Review.

PMID:
30320448
4.

A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders.

Saraf J, Bhattacharya P, Kalia K, Borah A, Sarmah D, Kaur H, Dave KR, Yavagal DR.

ACS Cent Sci. 2018 Jul 25;4(7):805-819. doi: 10.1021/acscentsci.8b00230. Epub 2018 Jun 27. Review.

5.

Novel Targets for Parkinson's Disease: Addressing Different Therapeutic Paradigms and Conundrums.

Rane P, Sarmah D, Bhute S, Kaur H, Goswami A, Kalia K, Borah A, Dave KR, Sharma N, Bhattacharya P.

ACS Chem Neurosci. 2018 Jul 11. doi: 10.1021/acschemneuro.8b00180. [Epub ahead of print]

PMID:
29957921
6.

Pharmacokinetics of Human Red Blood Cell Microparticles Prepared Using High-Pressure Extrusion Method.

Jy W, Rehni AK, Bidot C Jr, Navarro-Quero H, Haase CR, Koch S, Ahn YS, Dave KR.

Front Pharmacol. 2018 Jun 11;9:599. doi: 10.3389/fphar.2018.00599. eCollection 2018.

7.

Mitochondrial Dysfunction in Stroke: Implications of Stem Cell Therapy.

Sarmah D, Kaur H, Saraf J, Vats K, Pravalika K, Wanve M, Kalia K, Borah A, Kumar A, Wang X, Yavagal DR, Dave KR, Bhattacharya P.

Transl Stroke Res. 2018 Jun 20. doi: 10.1007/s12975-018-0642-y. [Epub ahead of print] Review.

PMID:
29926383
8.

Exposure to hypoglycemia and risk of stroke.

Smith L, Chakraborty D, Bhattacharya P, Sarmah D, Koch S, Dave KR.

Ann N Y Acad Sci. 2018 Nov;1431(1):25-34. doi: 10.1111/nyas.13872. Epub 2018 Jun 19. Review.

PMID:
29917249
9.

Inflammasomes in stroke: a triggering role for acid-sensing ion channels.

Vats K, Sarmah D, Kaur H, Wanve M, Kalia K, Borah A, Dave KR, Yavagal DR, Bhattacharya P.

Ann N Y Acad Sci. 2018 Nov;1431(1):14-24. doi: 10.1111/nyas.13852. Epub 2018 Jun 19. Review.

PMID:
29917247
10.

Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.

Rehni AK, Dave KR.

Cond Med. 2018;1(3):105-115. Epub 2018 Apr 20.

11.

Noncoding RNAs in ischemic stroke: time to translate.

Kaur H, Sarmah D, Saraf J, Vats K, Kalia K, Borah A, Yavagal DR, Dave KR, Ghosh Z, Bhattacharya P.

Ann N Y Acad Sci. 2018 Jun;1421(1):19-36. doi: 10.1111/nyas.13612. Epub 2018 Apr 23. Review.

PMID:
29683506
12.

Impact of Hypoglycemia on Brain Metabolism During Diabetes.

Rehni AK, Dave KR.

Mol Neurobiol. 2018 Dec;55(12):9075-9088. doi: 10.1007/s12035-018-1044-6. Epub 2018 Apr 10. Review.

PMID:
29637442
13.

Recurrent Hypoglycemia Exacerbates Cerebral Ischemic Damage in Diabetic Rats via Enhanced Post-Ischemic Mitochondrial Dysfunction.

Shukla V, Fuchs P, Liu A, Cohan CH, Dong C, Wright CB, Perez-Pinzon MA, Dave KR.

Transl Stroke Res. 2018 Mar 22. doi: 10.1007/s12975-018-0622-2. [Epub ahead of print]

PMID:
29569040
14.

Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.

Rehni AK, Shukla V, Perez-Pinzon MA, Dave KR.

Neuropharmacology. 2018 Jun;135:192-201. doi: 10.1016/j.neuropharm.2018.03.016. Epub 2018 Mar 15.

PMID:
29551689
15.

Myeloperoxidase and Neurological Disorder: A Crosstalk.

Pravalika K, Sarmah D, Kaur H, Wanve M, Saraf J, Kalia K, Borah A, Yavagal DR, Dave KR, Bhattacharya P.

ACS Chem Neurosci. 2018 Mar 21;9(3):421-430. doi: 10.1021/acschemneuro.7b00462. Epub 2018 Feb 2.

PMID:
29351721
16.

Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation.

Klingbeil KD, Koch S, Dave KR.

Int J Stroke. 2017 Jan 1:1747493017743797. doi: 10.1177/1747493017743797. [Epub ahead of print]

17.

Ischemic Preconditioning Protects Astrocytes against Oxygen Glucose Deprivation Via the Nuclear Erythroid 2-Related Factor 2 Pathway.

Narayanan SV, Dave KR, Perez-Pinzon MA.

Transl Stroke Res. 2018 Apr;9(2):99-109. doi: 10.1007/s12975-017-0574-y. Epub 2017 Nov 4.

PMID:
29103101
18.

Mesenchymal Stem Cell Therapy in Ischemic Stroke: A Meta-analysis of Preclinical Studies.

Sarmah D, Agrawal V, Rane P, Bhute S, Watanabe M, Kalia K, Ghosh Z, Dave KR, Yavagal DR, Bhattacharya P.

Clin Pharmacol Ther. 2018 Jun;103(6):990-998. doi: 10.1002/cpt.927. Epub 2017 Dec 14. Review.

PMID:
29090465
19.

Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell.

Sarmah D, Kaur H, Saraf J, Pravalika K, Goswami A, Kalia K, Borah A, Wang X, Dave KR, Yavagal DR, Bhattacharya P.

Transl Stroke Res. 2018 Aug;9(4):356-374. doi: 10.1007/s12975-017-0580-0. Epub 2017 Oct 26. Review.

PMID:
29075984
20.

Neuronal SIRT1 (Silent Information Regulator 2 Homologue 1) Regulates Glycolysis and Mediates Resveratrol-Induced Ischemic Tolerance.

Koronowski KB, Khoury N, Saul I, Loris ZB, Cohan CH, Stradecki-Cohan HM, Dave KR, Young JI, Perez-Pinzon MA.

Stroke. 2017 Nov;48(11):3117-3125. doi: 10.1161/STROKEAHA.117.018562. Epub 2017 Oct 10.

Supplemental Content

Loading ...
Support Center